相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
LANCET NEUROLOGY (2013)
Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics
Stacy A. Rudnicki et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials
James D. Berry et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Modeling drop-outs in amyotrophic lateral sclerosis
Paolo Messina et al.
CONTEMPORARY CLINICAL TRIALS (2012)
COMPARISON OF ANALYSIS APPROACHES FOR PHASE III CLINICAL TRIALS IN AMYOTROPHIC LATERAL SCLEROSIS
Brian C. Healy et al.
MUSCLE & NERVE (2012)
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Merit Cudkowicz et al.
NATURE MEDICINE (2011)
Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field
Linda Wittkop et al.
CLINICAL TRIALS (2010)
Effects of Gender in Amyotrophic Lateral Sclerosis
Pamela A. McCombe et al.
GENDER MEDICINE (2010)
Progression in ALS is not linear but is curvilinear
Paul H. Gordon et al.
JOURNAL OF NEUROLOGY (2010)
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
S. Zoccolella et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial
Petra Kaufmann et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Slower disease progression and prolonged survival in contemporary with amyotrophic patients lateral sclerosis - Is the natural history of amyotrophic lateral sclerosis changing?
Adam Czaplinski et al.
ARCHIVES OF NEUROLOGY (2006)
Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population
A Czaplinski et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R
EJ Kasarskis et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Survival of patients with amyotrophic lateral sclerosis in a population-based registry
A Millul et al.
NEUROEPIDEMIOLOGY (2005)
The ALSFRSr predicts survival time in an ALS clinic population
P Kaufmann et al.
NEUROLOGY (2005)
Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period
D Testa et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Functional outcome measures as clinical trial endpoints in ALS
BJ Traynor et al.
NEUROLOGY (2004)
An outcome study of riluzole in amyotrophic lateral sclerosis - A population-based study in Ireland, 1996-2000
BJ Traynor et al.
JOURNAL OF NEUROLOGY (2003)
Prognosis in amyotrophic lateral sclerosis - A population-based study
MA del Aguila et al.
NEUROLOGY (2003)
Early symptom progression rate is related to ALS outcome -: A prospective population-based study
A Chiò et al.
NEUROLOGY (2002)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
分享论文
